Prospective study of neoadjuvant chemotherapy with FEC100x4 for BRCAness cases in triple negative breast cancer
Not Applicable
Recruiting
- Conditions
- Breast cancer
- Registration Number
- JPRN-UMIN000029433
- Lead Sponsor
- Tokyo medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients who have been administered moderate doses of anti-cancer drugs. 2.Patients who have been undergone gastrointestinal surgery 3.Active double cancers 4.Pregnant, lactating, possible pregnancy, having oral contraceptive 5.Patients who the investigator judged unsuitable for this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pathologic complete response(pCR)
- Secondary Outcome Measures
Name Time Method